These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26890225)

  • 21. Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants.
    Yang J; Luo Y; Li J; Ma Y; Hu C; Jin S; Ye L; Cui S
    J Antimicrob Chemother; 2010 Mar; 65(3):453-9. PubMed ID: 20056688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay.
    Tamayo M; Santiso R; Gosalvez J; Bou G; Fernández JL
    BMC Microbiol; 2009 Apr; 9():69. PubMed ID: 19364397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli.
    Machuca J; Briales A; Labrador G; Díaz-de-Alba P; López-Rojas R; Docobo-Pérez F; Martínez-Martínez L; Rodríguez-Baño J; Pachón ME; Pascual A; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3203-15. PubMed ID: 25139837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
    González-Soltero R; García-Cañas A; Mohedano RB; Mendoza-Chamizo B; Botello E
    Rev Esp Quimioter; 2015 Jun; 28(3):139-44. PubMed ID: 26032998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterisation of quinolone resistance in Escherichia coli from animals in Turkey.
    Cengiz M; Buyukcangaz E; Arslan E; Mat B; Sahinturk P; Sonal S; Gocmen H; Sen A
    Vet Rec; 2012 Aug; 171(6):155, 1-4. PubMed ID: 22890400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of quinolone resistance in
    Chung YS; Hu YS; Shin S; Lim SK; Yang SJ; Park YH; Park KT
    J Vet Sci; 2017 Dec; 18(4):449-456. PubMed ID: 28385014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic screening for quinolone resistance in Escherichia coli.
    Dellgren L; Claesson C; Högdahl M; Forsberg J; Hanberger H; Nilsson LE; Hällgren A
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1765-1771. PubMed ID: 31214796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of qnr genes in clinical Enterobacteriaceae non-susceptible to fluoroquinolone in Poland].
    Piekarska K; Rzeczkowska M; Zacharczuk K; Chróst A; Januszkiewicz A; Bareja E; Olak M; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(3):211-9. PubMed ID: 23285775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
    Nawaz M; Sung K; Kweon O; Khan S; Nawaz S; Steele R
    Int J Antimicrob Agents; 2015 May; 45(5):471-6. PubMed ID: 25631675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones.
    Castanheira M; Deshpande LM; Jones RN; Farrell DJ
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):263-6. PubMed ID: 22321998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of land application of manure from enrofloxacin-treated chickens on ciprofloxacin resistance of Enterobacteriaceae in soil.
    Pourcher AM; Jadas-Hécart A; Cotinet P; Dabert P; Ziebal C; Le Roux S; Moraru R; Heddadj D; Kempf I
    Sci Total Environ; 2014 Jun; 482-483():269-75. PubMed ID: 24657372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant prevention concentrations of pradofloxacin for susceptible and mutant strains of Escherichia coli with reduced fluoroquinolone susceptibility.
    Marcusson LL; Komp Lindgren P; Olofsson SK; Hughes D; Cars O
    Int J Antimicrob Agents; 2014 Oct; 44(4):354-7. PubMed ID: 25129317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
    Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
    Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoroquinolone resistance in clinical and environmental isolates of Escherichia coli in Mexico City.
    Amábile-Cuevas CF; Arredondo-García JL; Cruz A; Rosas I
    J Appl Microbiol; 2010 Jan; 108(1):158-62. PubMed ID: 19548885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
    Lin CY; Huang SH; Chen TC; Lu PL; Lin WR; Chen YH
    J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.